Politics · 1 sources covering this

US Starts Section 301 Probe of Germany Over Pharmaceuticals

The US has launched a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
US Starts Section 301 Probe of Germany Over Pharmaceuticals
The US has launched a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/fa02baf0e3b4eb8c1f849bbf300ce3995fb8b104"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="US Starts Section 301 Probe of Germany Over Pharmaceuticals"></iframe>

US Starts Section 301 Probe of Germany Over Pharmaceuticals

How 1 sources are covering this

US Starts Section 301 Probe of Germany Over Pharmaceuticals

More from Politics

Vance’s Defense of Iran Deal Rests on Vague and Misleading Claims

Vance Delays Trip to Switzerland for Direct Talks on Iran Deal

Three Medals of Honor Awarded to Vietnam and Afghanistan Veterans

Burnham Wins UK Seat, Clearing Way for Run at Starmer’s Job

Reader

Trust & legal

Across the network